← 홈

전체 프로그램

ADC 1032 · Antibody 4684 · CGT 2713 · 다음 갱신 D-14 · 마지막 7월 31일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 3,531개
CGTBiologicstaleZhejiang UniversityPhase 1

NKG2D CAR NK and NKG2D CAR T cells (NKG2D CAR NK and NKG2D CAR T cells)

Patients With Advanced Solid Tumors With Liver Metastases Who Have Failed Standard Treatments · Patients With Advanced Solid Tumors With

#PatientsWithAdvancedSolidTumorsW#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 1상태 RECRUITING
CGTBiologicstaleZhejiang Provincial People's Ho…Phase 2

NKG2D CAR-NK with PD-1 Antibody (NKG2D CAR-NK with PD-1 Antibody)

Anaplastic Throid Carcinoma · PD-1

#PD-1#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleCelyad Oncology SAPhase 1

NKR-2 CAR-T Cells (NKR-2 CAR-T Cells)

AML, Adult; Myelodysplastic Syndromes · AML, Adult

#AMLAdult#CGT#Phase1#세포유전치료#CAR-T+5
임상시험 1상태 DISCONTINUED
CGTBiologicstaleNkarta, Inc.Phase 1

NKX101 - CAR NK cell therapy (NKX101 - CAR NK cell therapy)

Relapsed/Refractory AML; AML, Adult · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+5
임상시험 1상태 RECRUITING
ADCBiologicstaleNovelty Nobility, Inc.Phase 1

NN3201 (NN3201)

Gastrointestinal Stromal Tumors; Small-cell Lung Cancer · Gastrointestinal Stromal Tumors

#GastrointestinalStromalTumors#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 2

NUC-3373 + bevacizumab (NUC-3373 + bevacizumab)

Colorectal Cancer; Colorectal Neoplasms · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
CGTBiologicstaleNexcella Inc.Phase 2

NXC-201 CAR-T (NXC-201 CAR-T)

Light Chain (AL) Amyloidosis · Light Chain (AL) Amyloidosis

#LightChainALAmyloidosis#CGT#Phase2#세포유전치료#CAR-T+2
임상시험 1상태 RECRUITING
CGTBiologicstaleCentre Hospitalier Universitair…Phase 1

NY-ESO-1 TCR redirected autologous T cell product (NY-ESO-1 TCR redirected autologous T cell product)

Advanced Melanoma; Melanoma Metastatic · Advanced Melanoma

#AdvancedMelanoma#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleShenzhen University General Hos…Preclinical

NY-ESO-1 TCR-T (NY-ESO-1 TCR-T)

Advanced Soft-tissue Sarcoma · Advanced Soft-tissue Sarcoma

#AdvancedSoft-tissueSarcoma#CGT#Preclinical#세포유전치료#CAR-T+2
임상시험 1상태 RECRUITING
CGTBiologicstaleUniversity of ChicagoPhase 2

NY-ESO-1 TCR/ dnTGFβRII (NY-ESO-1 TCR/ dnTGFβRII)

Ovarian Cancer; Advanced Malignant Solid Tumor · Ovarian Cancer

#OvarianCancer#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleM.D. Anderson Cancer CenterPhase 1

NY-ESO-1 TCR/IL-15 NK (NY-ESO-1 TCR/IL-15 NK)

Synovial Sarcoma; Myxoid/Round Cell Liposarcoma · Synovial Sarcoma

#SynovialSarcoma#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleUniversity of PennsylvaniaPhase 1

NY-ESO-1 redirected autologous T cells with CRISPR edited endogenous TCR and PD-1 (NY-ESO-1 redirected autologous T cells with CRISPR edited endogenous TCR and PD-1)

Multiple Myeloma; Melanoma · PD-1

#PD-1#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 DISCONTINUED
ADCBiologicstaleOncomatryx Biopharma S.L.Phase 1

Nab-paclitaxel + Gemcitabine (Nab-paclitaxel + Gemcitabine)

Pancreatic Adenocarcinoma Metastatic · Pancreatic Adenocarcinoma Metastatic

#PancreaticAdenocarcinomaMetastat#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
AntibodystaleHenan Cancer HospitalPhase 3

trastuzumab (Herceptin, Nab-paclitaxel+ trastuzumab+ patuzumab)

Breast Cancer,HER2-positive · HER2

#HER2#Antibody#Phase3#항체#면역항체+4
임상시험 1상태 RECRUITING
CGTBiologicstaleHadassah Medical OrganizationPhase 1

Naive HBI0101 CAR-T (Naive HBI0101 CAR-T)

Relapsed/Refractory Multiple Myeloma (MM) · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
AntibodystaleTakedaPhase 2

Namilumab (Namilumab)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED
CGTBiologicstaleHebei Senlang Biotechnology Inc…Phase 2

Nanobody-Based CD19/CD22 Tandem Dual CAR-T (Nanobody-Based CD19/CD22 Tandem Dual CAR-T)

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
AntibodystaleWeill Medical College of Cornel…Phase 1

Naptumomab Estafenatox (Naptumomab Estafenatox)

Urothelial Carcinoma · Urothelial Carcinoma

#UrothelialCarcinoma#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleNeoTX Therapeutics Ltd.Phase 1

durvalumab (Imfinzi, Naptumomab estafenatox and durvalumab)

ER+ Breast Cancer; Ovarian Cancer · HER2

#HER2#Antibody#Phase1#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleAbGenomics B.V Taiwan BranchPhase 2

Neihulizumab Treatment (Neihulizumab Treatment)

Steroid-refractory aGvHD Subsequent to Allogeneic Hematopoietic Cell Transplantation · FRα

#FR#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 DISCONTINUED

135 / 177 페이지

← 이전다음 →